Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Catalent to buy Cook Pharmica for $950m in cash

Catalent Inc has announced it will buy Cook Pharmica for $950m in cash to boost its high tech drug production business.

Samsung Bioepis will use CMOs to make Ontruzant if it is approved

Samsung Bioepis will use contractors to make its candidate Herceptin biosimilar Ontruzant if it goes on to be approved in Europe.

Bayer takes a shine to Berkeley Light's Beacon biologics workflow tech

Bayer has signed a deal to use Berkeley Lights’ automated biological workflow platform for cell line development and antibody discovery.

Synpromics expansion to support growing gene control business

Moving to a larger facility will help Scottish firm Synpromics Ltd increase its gene control and cell line services presence, the firm says.

Remicade biosimilar: J&J’s ‘fear and loathing’ subdued as Pfizer slugs it out

Fears of Remicade competition have not manifested in significant growth declines for Johnson & Johnson, but Pfizer says US payers and physicians are slowly getting comfortable with biosimilars.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...